Stephen  Gunstream net worth and biography

Stephen Gunstream Biography and Net Worth

Stephen Gunstream has served as a director and our President and Chief Executive Officer since May 2020 and served as our Chief Business Officer from December 2019 to May 2020. Stephen has more than 20 years of sales, marketing, research and development, and general management experience in the life sciences industry. From June 2015 to December 2019, Stephen served in multiple roles at Becton Dickinson & Co. (“BD”) (NYSE: BDX), a global medical technology company, most recently as Vice President and General Manager of BD Biosciences, where he was responsible for leading BD’s flow cytometry and genomics business. From 2008 to 2015, he served in multiple roles at Integrated DNA Technologies, Inc. (“IDT”), a leading supplier of custom nucleic acids, most recently as Chief Commercial Officer, where he was responsible for product development, global sales, and global marketing. Under Stephen’s leadership, IDT took advantage of its core DNA manufacturing strengths and launched several highly innovative products that re-positioned the company in the market, including the xGen® Exome Panel and gBlocks® Gene Fragments, the latter for which he was also named a co-inventor. Prior to IDT, from 2001 to 2008, Stephen held multiple product development and business development roles with Applied Biosystems, Inc. (now part of Thermo Fisher Scientific, Inc.), a biomedical technology company. Stephen received a bachelor’s degree in biomedical engineering from Northwestern University and an MBA from the Fuqua School of Business at Duke University. He is a named inventor on 10 issued patents and more than 25 pending patents.​

What is Stephen Gunstream's net worth?

The estimated net worth of Stephen Gunstream is at least $1.18 million as of July 12th, 2024. Mr. Gunstream owns 243,497 shares of Alpha Teknova stock worth more than $1,176,091 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Gunstream may own. Additionally, Mr. Gunstream receives a salary of $937,790.00 as CEO at Alpha Teknova. Learn More about Stephen Gunstream's net worth.

How old is Stephen Gunstream?

Mr. Gunstream is currently 44 years old. There are 2 older executives and no younger executives at Alpha Teknova. Learn More on Stephen Gunstream's age.

What is Stephen Gunstream's salary?

As the CEO of Alpha Teknova, Inc., Mr. Gunstream earns $937,790.00 per year. Learn More on Stephen Gunstream's salary.

How do I contact Stephen Gunstream?

The corporate mailing address for Mr. Gunstream and other Alpha Teknova executives is , , . Alpha Teknova can also be reached via phone at 831-637-1100 and via email at [email protected]. Learn More on Stephen Gunstream's contact information.

Has Stephen Gunstream been buying or selling shares of Alpha Teknova?

Stephen Gunstream has not been actively trading shares of Alpha Teknova within the last three months. Most recently, on Friday, July 12th, Stephen Gunstream bought 80,645 shares of Alpha Teknova stock. The stock was acquired at an average cost of $1.24 per share, with a total value of $99,999.80. Following the completion of the transaction, the chief executive officer now directly owns 243,497 shares of the company's stock, valued at $301,936.28. Learn More on Stephen Gunstream's trading history.

Who are Alpha Teknova's active insiders?

Alpha Teknova's insider roster includes Martha Demski (Director), Ken Gelhaus (Insider), Stephen Gunstream (CEO), Matthew Lowell (CFO), J. Mackowski (Director), and Damon Terrill (General Counsel). Learn More on Alpha Teknova's active insiders.

Are insiders buying or selling shares of Alpha Teknova?

In the last twelve months, insiders at the sold shares 1 times. They sold a total of 8,000 shares worth more than $40,480.00. The most recent insider tranaction occured on June, 27th when Director Martha J Demski sold 8,000 shares worth more than $40,480.00. Insiders at Alpha Teknova own 12.5% of the company. Learn More about insider trades at Alpha Teknova.

Information on this page was last updated on 6/27/2025.

Stephen Gunstream Insider Trading History at Alpha Teknova

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/12/2024Buy80,645$1.24$99,999.80243,497View SEC Filing Icon  
5/12/2023Buy4,665$1.67$7,790.55108,798View SEC Filing Icon  
11/14/2022Buy1,716$4.23$7,258.6861,008View SEC Filing Icon  
8/15/2022Buy18,000$5.13$92,340.0018,000View SEC Filing Icon  
5/13/2022Buy1,292$10.93$14,121.561,292View SEC Filing Icon  
See Full Table

Stephen Gunstream Buying and Selling Activity at Alpha Teknova

This chart shows Stephen Gunstream's buying and selling at Alpha Teknova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alpha Teknova Company Overview

Alpha Teknova logo
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Read More

Today's Range

Now: $4.83
Low: $4.70
High: $4.87

50 Day Range

MA: $5.09
Low: $4.28
High: $6.37

2 Week Range

Now: $4.83
Low: $3.94
High: $10.37

Volume

66,052 shs

Average Volume

166,336 shs

Market Capitalization

$258.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4